NCT07471776 clinical trial report covering Fludeoxyglucose F-18, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07471815 clinical trial report covering Risedronate Sodium, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20260974 clinical trial report covering AST-001, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07469956 clinical trial report covering Toripalimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07470983 clinical trial report covering HRS-1780, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07470879 clinical trial report covering Etrasimod Arginine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07471841 clinical trial report covering Olutasidenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20260898 clinical trial report covering HQ2216, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07469306 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07470489 clinical trial report covering Cemiplimab-RWLC, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07468916 clinical trial report covering Ropeginterferon alfa-2b-NJFT, Phase 2, endpoints, sponsor, geography, readout timing and development white space

ChiCTR2600120535 clinical trial report covering Butaselen, Phase 2, endpoints, sponsor, geography, readout timing and development white space.